American Biotechnology Co

Basic Information

7658 Standish Pl - Ste 107
Rockville, MD, 20855

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 10


  1. EVALUATION OF THE IMMUNE MODULATOR MFBL FOR ANTIVIRAL EFFICACY

    Amount: $495,000.00

    THE METHYLFURYLBUTYROLACTONES (MFBL'S) ARE A UNIQUE GROUP OF CHEMICAL COMPOUNDS THAT COMPRISE A NEW GROUP OF SYNTHETIC IMMUNOMODULATORS. THE COMPOUNDS ARE WATER SOLUBLE, RELATIVELY NON-TOXIC, ECONOMIC ...

    SBIR Phase II 1988 Navy Department of Defense
  2. EVALUATION OF THE IMMUNE MODULATOR MFBL FOR ANTIVIRAL EFFICACY

    Amount: $50,000.00

    N/A

    SBIR Phase I 1987 Navy Department of Defense
  3. INTERFACE

    Amount: $50,000.00

    A MAJOR OBJECTIVE OF THIS STUDY IS TO INVESTIGATE THE UTILITY OF A NEW AND INNOVATIVE LIQUID MICROCARRIER (MC) SYSTEM FOR CLONING AND PROPAGATING HUMAN TUMOR CELLS IN VITRO. THIS NEW PATENTED TECHNOLO ...

    SBIR Phase I 1986 Department of Health and Human Services
  4. THE GOAL OF THIS PROJECT WILL BE TO SCREEN NEW DERIVATIVES OF L-ASCORBIC ACID ADDUCTS CLASSIFIED AS METHYLFURYLBUTYROLACTONES, ALSO REFERRED TO AS NAFOCARE B.

    Amount: $50,000.00

    THE GOAL OF THIS PROJECT WILL BE TO SCREEN NEW DERIVATIVES OF L-ASCORBIC ACID ADDUCTS CLASSIFIED AS METHYLFURYLBUTYROLACTONES, ALSO REFERRED TO AS NAFOCARE B. WORKING IN COLLABORATION WITH A SYNTHETIC ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. AND ITS POTENTIAL APPLICATION TO HUMAN HYBRIDOMA TECHNOLOGY.

    Amount: $49,593.00

    AND ITS POTENTIAL APPLICATION TO HUMAN HYBRIDOMA TECHNOLOGY.THIS PROJECT INVOLVES DETERMINING THE ABILITY OF A NEW CLASS OF SYNTHETIC BIOLOGICAL RESPONSE MODIFIERS (BRM) KNOWN AS METHYLFURYLBUTYROLACT ...

    SBIR Phase I 1985 Department of Health and Human Services
  6. ALTHOUGH INVESTIGATION INTO BIOLOGICAL RESPONSE MODIFIERS HAS INCREASED RECENTLY, MOST OF THE EFFORT HAS BEEN TOWARDS POTENTIATING THE HOST'S CELL-MEDIATED IMMUNITY.

    Amount: $48,529.00

    ALTHOUGH INVESTIGATION INTO BIOLOGICAL RESPONSE MODIFIERS HAS INCREASED RECENTLY, MOST OF THE EFFORT HAS BEEN TOWARDS POTENTIATING THE HOST'S CELL-MEDIATED IMMUNITY. DATA ACCUMULATED BY OUR LABORATORI ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government